https://www.infectiousdiseaseadvisor.com/home/topics/covid19/prophylactic-use-of-tixagevimab-cilgavimab-after-covid-19-exposure-is-limited/
0
0
Prophylactic Use of Tixagevimab-Cilgavimab After COVID-19 Exposure Is Limited - Infectious Disease Advisor
1/3/23 at 2:40pm
Organization
Infectiousdiseaseadvisor.com
Authors
Jessica Nye PhD
Details
30 words
Summarize
Infectious Diseases Health Evusheld post-exposure prophylaxis
Researched evaluated the use of tixagevimab-cilgavimab as post-exposure prophylaxis against symptomatic COVID-19 infection.
Create an account or login to join the discussion